Onderneming Verona Pharma Plc London S.E.
Aandelen
GB00B06GSH43
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
||
- GBX | - |
09/05 | Verona Pharma tekent financieringsovereenkomsten voor maximaal $650 miljoen | MT |
09/05 | Aandelen Verona Pharma dalen na groter verlies in Q1 | MT |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 59 | 01-02-20 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01-03-20 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-23 |
Tara Rheault
CTO | Chief Tech/Sci/R&D Officer | 49 | 01-01-19 |
Kathleen Rickard
CTO | Chief Tech/Sci/R&D Officer | 65 | 01-02-19 |
Victoria Stewart
IRC | Investor Relations Contact | - | 01-02-19 |
Corporate Officer/Principal | - | 01-06-20 | |
Ostra Jewell
HRO | Human Resources Officer | - | 01-09-22 |
Caroline Diaz
LAW | General Counsel | - | 01-10-21 |
Matthew Casbon
SAM | Sales & Marketing | - | 24-08-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17-06-16 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12-09-16 |
David Ebsworth
CHM | Chairman | 69 | 01-12-14 |
Director/Board Member | 71 | 10-09-15 | |
Martin Edwards
BRD | Director/Board Member | 68 | 01-04-19 |
Director/Board Member | 68 | 10-09-15 | |
Chief Executive Officer | 59 | 01-02-20 | |
Director/Board Member | 59 | 01-09-23 | |
Lisa Deschamps
BRD | Director/Board Member | 52 | 01-03-21 |
Michael Austwick
BRD | Director/Board Member | 54 | 01/02 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 608 138 246 | 458 671 402 ( 75,42 %) | 0 | 75,42 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+3,91% | 109 mld. | |
+10,87% | 105 mld. | |
+1,28% | 22,25 mld. | |
-13,14% | 22,09 mld. | |
-7,05% | 18,68 mld. | |
-38,36% | 17,58 mld. | |
-10,66% | 16,85 mld. | |
+3,75% | 13,76 mld. | |
+36,70% | 12,46 mld. |
- Beurs
- Aandelen
- Koers VRNA
- Koers
- Onderneming Verona Pharma Plc